Dong Kun Lee1, Ji Won Seo1, Heon Soo Park1, Myung Koo Kang1, Ae Lan Jang1, Joon Hyung Lee2, Jong Chul Hong3. 1. Department of Otolaryngology-Head and Neck Surgery, Dong-A University College of Medicine, Busan, Korea. 2. Department of Radiology, Dong-A University College of Medicine, Busan, Korea. 3. Department of Otolaryngology-Head and Neck Surgery, Dong-A University College of Medicine, Busan, Korea santa@dau.ac.kr hyungnz@damc.or.kr.
Abstract
OBJECTIVE: Ethanol ablation has been known as an effective, easy, and safe treatment of cystic thyroid lesions. The objective of the present study was to evaluate efficacy of ethanol ablation as a minimally invasive management of thyroglossal duct cyst (TGDC). METHODS: Between January 2012 and July 2013, 9 TGDC patients were diagnosed and treated with ethanol ablation. We evaluated the treatment outcomes with the change of volume reduction and the improvement of symptomatic and cosmetic complaints and complications. RESULTS: Initial mean tumor volume was 8.9 mL (range, 0.2-36.9 mL) in ultrasonography. The mean number of the treatment sessions was 1.7 (range, 1-3 sessions). At last follow-up, the mean volume of the treated thyroglossal duct cyst decreased significantly from 8.9 mL to 1.9 mL (P = .019; volume reduction rate = 76.6%). Treatment success rate was 77.8% (7/9). Mean symptoms and cosmetic-grading scores improved from 5.2 to 3.1 and from 5.3 to 3.1 (P = .062). No significant complications were observed during follow-up. CONCLUSION: Ethanol ablation is a feasible and convenient procedure without surgical scars and hospitalization for TGDC patients. Favorable outcomes can be achieved without significant complications.
OBJECTIVE:Ethanol ablation has been known as an effective, easy, and safe treatment of cystic thyroid lesions. The objective of the present study was to evaluate efficacy of ethanol ablation as a minimally invasive management of thyroglossal duct cyst (TGDC). METHODS: Between January 2012 and July 2013, 9 TGDC patients were diagnosed and treated with ethanol ablation. We evaluated the treatment outcomes with the change of volume reduction and the improvement of symptomatic and cosmetic complaints and complications. RESULTS: Initial mean tumor volume was 8.9 mL (range, 0.2-36.9 mL) in ultrasonography. The mean number of the treatment sessions was 1.7 (range, 1-3 sessions). At last follow-up, the mean volume of the treated thyroglossal duct cyst decreased significantly from 8.9 mL to 1.9 mL (P = .019; volume reduction rate = 76.6%). Treatment success rate was 77.8% (7/9). Mean symptoms and cosmetic-grading scores improved from 5.2 to 3.1 and from 5.3 to 3.1 (P = .062). No significant complications were observed during follow-up. CONCLUSION:Ethanol ablation is a feasible and convenient procedure without surgical scars and hospitalization for TGDC patients. Favorable outcomes can be achieved without significant complications.
Authors: Esther Lee; Christopher Badger; Ishwarya S Mamidi; Daniel A Benito; Lilun Li; Joseph F Goodman; Punam G Thakkar; Arjun Joshi Journal: Ultrasound Date: 2021-07-21
Authors: Mi Sun Chung; Jung Hwan Baek; Jeong Hyun Lee; Young Jun Choi; Jong Ho Yoon; Soon Yuhl Nam; Seong Chul Kim; Jin Yong Sung; Seon Mi Baek; Dong Gyu Na Journal: Eur Radiol Date: 2016-12-12 Impact factor: 5.315